Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 134INDUSTRY 91NETWORK 6NIH 4UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Neoplastic Cells, Circulating 1

Interventions

Gemcitabine 15Cisplatin 12Radiotherapy 11Metformin 8Fluorouracil 8Capecitabine 8Paclitaxel 7Oxaliplatin 7Exercise 7Indocyanine Green 6Docetaxel 6Cyclophosphamide 6Control Groups 6Surveys and Questionnaires 5Standard of Care 5Nivolumab 5Letrozole 5Irinotecan 5pembrolizumab 4durvalumab 4Zoledronic Acid 4Vinorelbine 4Saline Solution 4Preoperative Exercise 4Magnetic Resonance Spectroscopy 4Leucovorin 4Ifosfamide 4Gefitinib 4Drug Therapy 4Carboplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × OTHER_GOV × 130-nm albumin-bound paclitaxel × Clear all
NCT02707159 2023-03-08

PACT-ACT-v6

Helse Stavanger HF

Phase 2 Completed
70 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡